Limits and uncertainty around telehealth reimbursement have generally been an impediment to adoption. For the duration of the COVID-19 crisis, that burden was eased somewhat, but now the new typical is starting off to get form. What barriers still keep on being to telehealth reimbursement, and how could they be prevail over? To remedy that problem, host Jonah Comstock and Health care Finance Information Taking care of Editor Susan Morse welcome McKinsey & Company partners Oleg Bestsennyy and Gunjan Khanna.
This episode is introduced to you by BlueJeans.
Like what you listen to? Subscribe to the podcast on Apple Podcasts, Spotify or Google Engage in!
Speaking factors:
- COVID-19 reimbursement improvements and which of them will stick around
- Adoption classes learned and how they’ll impact reimbursement coverage
- Holistic tele-treatment and treatment further than the movie go to
- Influence of new entrants and innovation on the place
- Is cost-for-support reimbursement an innovation blocker?
- Reimbursement for distinctive telehealth modalities
- Time to lead alternatively than abide by for non-public payers?
- The still-unresolved problem of induced utilization
- The increase of price-primarily based treatment and hybrid treatment versions
- Telehealth reimbursement and wellbeing equity
- How are sufferers experience about telehealth now?
- Closing feelings: the upcoming of telehealth reimbursement
More about this episode:
Report exhibits ‘vast improvement’ in state telehealth reimbursement policies
COVID-19 may perhaps forever change the telehealth landscape, from reimbursement to utilization
Telehealth reimbursement parity spurs insurance provider worries of overutilization
CMS will reimburse for eleven new telehealth services through the community wellbeing crisis
Congressional action is wanted for telehealth not to return to a rural reward, Seema Verma claims
Telehealth: A quarter-trillion-dollar publish-COVID-19 fact? (McKinsey)
COVID-19 Buyer Health care Insights: What 2021 may perhaps hold (McKinsey)
How COVID-19 has changed the way US shoppers believe about healthcare (McKinsey)
